Korro Bio, Inc.
KRRONasdaqCIK 1703647HealthcareFiscal year ends Dec 31
All transactions: 4
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-26 | Lynx1 Capital Management LP10% owner | Purchase | 25,124 | $11.7454 | $295.1k | Form 4 |
| 2026-10-23 | Lynx1 Capital Management LP10% owner | Purchase | 2,510 | $12.1061 | $30.4k | Form 4 |
| 2026-10-22 | Lynx1 Capital Management LP10% owner | Purchase | 40,000 | $11.0366 | $441.5k | Form 4 |
| 2026-10-22 | Lynx1 Capital Management LP10% owner | Purchase | 12,175 | $9.6764 | $117.8k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 27, 2026, 17:32 ET. Listed shows no prices and gives no investment advice.